A randomized trial of testosterone therapy in males with rheumatoid arthritis

British Journal of Rheumatology

Volumn 35, Issue 6, 1996, Pages 568-573

  Hall, G M ^a   Larbre, J P ^a   Spector, T D ^b   Perry, L A ^a   Da Silva, J A P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Bone density; Disease activity; Male; Rheumatoid arthritis; Testosterone; Vertebral fracture

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ESTRADIOL; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULT; AGED; ARTICLE; BACKACHE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; ESTRADIOL BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TESTOSTERONE BLOOD LEVEL; VERTEBRA FRACTURE;

EID: 0029920229     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.6.568     Document Type: Article

References (27)

1. Schuurs AHVM, Verheul HAM. Effects of gender and sex steroids on the immune response. J Steroid Biochem Mol Biol 1990;35:157-72.
2. Da Silva JAP, Hall GM. The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillière's Clin Rheumatol 1992;6:193-219.
3. Cutolo M, Accardo S, Villaggio B et al. Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 1992;35:1007-15.
4. Ollier W, Spector T, Silman A. Are certain HLA haplotypes responsible for low testosterone levels in males. Dis Markers 1989;7:139-43.
5. Spector TD, Perry LA, Tubb G, Silman AJ, Huskisson EC. Low free testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988;47:65-8.
6. Masi AT, Chatterton RT, Comstock GW, Malamet RL, Hochberg MC. Decreased serum dehydroepiandrosterone sulphate levels before onset of RA in younger premenopausal women: a controlled prospective study. Arthritis Rheum 1994;37:S315.
7. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.
8. Hall GM, Spector TD, Griffin AJ, Jawad ASM, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993;36:1510-6.
9. Laan RFJM, Buijs WCAM, Verbeek ALM et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
10. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721-8.
11. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 1993;306:558.
12. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49-52.
13. Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology and prevention. Medicine 1990;69:137-52.
14. Kley HK, Herrmann J, Morgner KD, Kruskemper HL. Effects of testosterone oenanthate on plasma concentrations of thyroxine, cortisol, testosterone and hormone binding proteins in patients with hypogonadism. Horm Metab Res 1973;5:271-4.
15. McCloskey EV, Spector TD, Eyres KS et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporosis Int 1993;3:138-47.
16. Gordon C, Beastal GH, Thomson JA, Sturrock RD. Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis. Q J Med 1986;60:671-9.
17. Semple CG, Gray CE, Beastall GH. Adrenal androgens and illness. Acta Endocrinol (Copenhagen) 1987;116:155-60.
18. Garton MJ, Reid DM. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis; effects of low-dose corticosteroids. Arthritis Rheum 1993;36:222-7.
19. Compston JE, Crawley EO, Evans C, O'Sullivan MM. Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis 1988;47:660-4.
20. Butler RC, Davie MWJ, Worsfold M, Sharp CA. Bone mineral content in patients with rheumatoid arthritis: relationship to low dose steroid therapy. Br J Rheumatol 1991;30:86-90.
21. Drinka PJ, Bauwens SF, DeSmet AA. Atraumatic vertebral deformities in elderly males. Calcif Tissue Int 1987;41:299-302.
22. Zetterberg C, Mannius S, Mellstrom D, Rundgren A, Astrand K. Osteoporosis and back pain in the elderly. A controlled epidemiologic and radiographic study. Spine 1990;15:783-6.
23. Seeman E, Melton LJ III, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977-83.
24. De Vernejoul MC, Bielekopf J, Hevre M et al. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle aged men. Clin Orthopaed Rel Res 1983;179:107-15.
25. Anderson DC. Osteoporosis in men. Br Med J 1992;305:489-90.
26. Hall GM, Daniels M, Doyle DV, Spector TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994;37:1499-505
27. Orwoll S, Oviatt S. Transdermal testosterone supplementation in normal men: effects on bone and mineral metabolism. J Bone Miner Res 1992;7(suppl. 1):913.